Clonal B cell populations in a minority of patients with Hashimoto’s thyroiditis
- 1Department of Pathology, Royal University Hospital, Saskatoon, Saskatchewan S7N 0W8, Canada
- 2Department of Laboratory Medicine, Regina Qu’apelle Health Region, Saskatchewan S4T 1A5, Canada
- 3Internal Medicine (Division of Endocrinology), Royal University Hospital, University of Saskatchewan, Saskatchewan, Canada
- Correspondence to:
Dr A Saxena
Department of Pathology, c/o Royal University Hospital, 103 Hospital Drive, Saskatoon, SK S7N 0W8, Canada;
- Accepted 6 May 2004
Background: Hashimoto’s thyroiditis (HT) is a risk factor for thyroid lymphoma, and clonal B cell populations in HT support this link. The literature on B cell clonality in HT is controversial.
Aims: To identify clonal B cell populations in HT and to assess their usefulness in differentiating HT from mucosa associated lymphoid tissue (MALT) lymphoma and predicting future development of lymphoma.
Methods: DNA from formalin fixed, paraffin wax embedded blocks of thyroid specimens from 10 patients with HT and two thyroid MALT lymphomas was analysed for B cell clonality by seminested polymerase chain reaction (PCR) using FRIII/LJH and FRIII/VLJH primers to amplify the IgH gene VDJ region. In one case, PCR products were sequenced. Immunohistochemistry was performed by labelled streptavidin–biotin technique using antibodies to: CD45, CD45RO, CD3, CD20, and cytokeratin.
Results: The histopathological and clinical findings were characteristic of HT. Clonal bands were seen in three and a polyclonal smear pattern was seen in seven cases. The clonal bands in HT were associated with a background smear, and could not be reproduced from other blocks from the same case or from deeper sections of the same block. The clonal bands in thyroid lymphomas were not associated with a background smear and were reproducible. None of the patients with clonal B cells has developed malignant lymphoma during a follow up of 10–13 years.
Conclusions: B cell clonal bands in HT have different features from those in lymphoma (non-pure and non-reproducible) and do not predict future development of lymphoma.
- Hashimoto’s thyroiditis
- immunoglobulin gene rearrangements
- polymerase chain reaction
- thyroid lymphoma
Clonal B cell populations have been seen in lymphoid hyperplasia of acquired mucosa associated lymphoid tissue (MALT) at different sites including the stomach,1,2 salivary glands,3,4 skin,5,6 ocular adnexa,7 and breast.7 Although MALT lymphomas develop from acquired MALT,8 the B cell clonal populations in hyperplasia of acquired MALT are not always malignant.1–7 Furthermore, these clonal populations do not necessarily evolve into malignant lymphoma.1–7
Primary MALT lymphomas of the thyroid almost invariably develop from pre-existing Hashimoto’s thyroiditis (HT) (relative risk, 67).9 Although not a mucosal site, the lymphoid tissue in HT has many features of MALT and shows more pronounced plasma cell differentiation.10 The histological features of HT show considerable overlap with MALT lymphoma in the thyroid.10,11 Although B cell clonality has been demonstrated in HT,7,12 this finding was not confirmed in subsequent studies.10,13,14
“Primary mucosa associated lymphoid tissue lymphomas of the thyroid almost invariably develop from pre-existing Hashimoto’s
The aims of our study were to determine the presence of clonal B cell populations in HT, to ascertain the importance of clonality in distinguishing HT from MALT lymphoma, and to evaluate its role in predicting the subsequent development of lymphoma. We have found that a minority of HT specimens (with no morphological evidence of low grade MALT lymphoma in multiple sections) contain monoclonal B cells. The presence of this clonal population does not equate to malignancy, and is not a reliable marker for predicting the future development of lymphoma.
MATERIAL AND METHODS
Formalin fixed, paraffin wax embedded material was taken from 10 consecutive cases (six from the pathology archives of the Royal University Hospital, University of Saskatchewan and four from the Regina Quapelle Health Region, Canada). All patients had a clinical diagnosis of and histopathological features characteristic of HT. Multiple sections (minimum, eight; range, eight to 14) were evaluated for morphological evidence of low grade MALT lymphoma; none had histological features of low grade MALT lymphoma.10,11,15 Lymphoepithelial lesions were defined as clusters of three or more lymphocytes in the glandular epithelium. In addition, the following control specimens were evaluated for clonal B cell populations: low grade MALT lymphoma of the thyroid (n = 2); unremarkable thyroid, obtained at necropsy (n = 3); and thyroid lesions associated with a lymphoid infiltrate: thyrotoxicosis (n = 2) and non-specific lymphocytic thyroiditis (n = 3).
Patient chart review
Patient files at the medical records department were reviewed for clinical presentation, laboratory findings, management, and follow up information. The registration database of the Saskatchewan Cancer Registry, where all the patients from Saskatchewan (the population base of our study) with a diagnosis of any malignancy are registered, was reviewed specifically for the development of thyroid lymphoma.
The labelled streptavidin–avidin technique16 was used to localise the primary antibodies after microwave antigen retrieval. The primary monoclonal antibodies used in our study were directed at: CD45, CD45RO, CD3, CD20, κ chain, λ chain, CD21, CD35, and cytokeratin.
Immunoglobulin gene rearrangement by PCR
DNA was extracted from 5 μm sections using the QIAamp tissue kit (Qiagen, Hilden, Germany) and the amount of DNA was adjusted to 500 ng/μl. A modified seminested protocol was used for amplification of the VDJ region of the immunoglobulin heavy chain gene (IgH).17–19 Two rounds of PCR were performed, the first with the FRIII (5′–ACACGGC[C/T][G/C]TGTATTACTGT-3′) and LJH (5′-TGAGGAGACGGTGACC-3′) primers, and the second with the FRIII and VLJH (5′-GTGACCAGGGTNCCTTGGCCCCAG-3′) primers.20,21 The total volume of the reaction mixture was 25 μl; it contained 500 ng of template DNA (in 1 μl); 2.0 μl of dNTP mix (working concentration, 10mM of each dNTP; Gibco BRL Life Technologies, Burlington, Ontario, Canada); 0.5 μl of each primer (working concentration, 2 pM/μl; Gibco BRL Life Technologies); 1.5 μl of Red-Taq DNA polymerase (1 unit/μl; Sigma, St Louis, Missouri, USA); 2.5 μl of 10× Red Taq PCR reaction buffer (Sigma), containing 100mM Tris/HCL (pH 8.3), 500mM KCL, 11mM MgCl2, and 0.1% gelatin; 2.5 μl of 50mM MgCl2; and PCR water (VWR Canlab, Mississauga, Ontario, Canada) to a final volume of 25 μl. Aliquots (1 μl) of the first round PCR product were amplified in the second round PCR. Amplification (first round, 25 cycles; second round, 20 cycles) was carried out in a PTC-200 DNA engine thermocycler (MJ Research Inc, Watertown, Massachusetts, USA) as follows: pre-PCR segment, initial denaturation (five minutes at 95°C, one cycle), PCR segment (denaturation for one minute at 94°C, annealing for one minute at 50°C, and extension for one minute at 72°C), and a post-PCR segment, final extension (10 minutes at 72°C). Each amplification was duplicated and a 5 μl aliquot of the PCR products was electrophoresed for 75 minutes at 165 V on 10% polyacrylamide gels (acrylamide/bisacrylamide content of 29/1); this can resolve three nucleotide base pair differences.22 The presence of clonal bands of different sizes (base pairs) was taken as evidence of bands of different sequences. The products were visualised under ultraviolet light after staining with ethidium bromide on a gel documentation system (Gel-Doc 2000; BioRad, Mississauga, Ontario, Canada), and the exact size was determined using the software program (Quantity One, BioRad).
Clonality was established by the presence of one or two discrete bands in the 80–140 bp region,17 and polyclonality by a diffuse smear pattern or multiple faint indistinct bands.22 All tests were run in duplicate. To assess the reproducibility of clonal bands, DNA was amplified from different areas of the lesion, sections from a deeper level, or sections from another block. The deeper sections represented levels 18–20 (90–100 μm deeper, each section being 5 μm thick). The next adjacent 5 μm section was examined for histological features, specifically, the presence of lymphoid follicles. Standard controls were run with each batch of PCR, these included: reagent control (no template DNA), negative tissue control (sample with no IgH gene rearrangement), and positive tissue control (known lymphoma case previously shown to have a clonal band by PCR). Amplification of β actin was used as evidence of amplifiable DNA from all samples. Sequencing of PCR products was performed in one case (case 3).
Table 1 summarises the clinical features of the patients. All patients were women with an age range of 39 to 69 years (mean, 54). In all patients, the disease presented as a goitre of variable duration (one month to two years). At presentation, six patients were euthyroid and four were hypothyroid. Partial thyroidectomy was performed in all patients. Nine patients have remained well, whereas one died after one year as a result of an unrelated cause. Review of the patient files showed no evidence of recurrent thyroid enlargement, systemic lymphadenopathy, organomegaly, or leucocytosis. None of the patients has developed lymphoma during the clinical follow up (range, eight to 13 years), including three patients with a clonal B cell population (follow up, 10–13 years).
Histopathological and immunohistochemical findings
All patients had classic features of HT. An extensive lymphoid infiltrate was associated with acinar atrophy and Hurthle cell metaplasia (fig 1), and in four cases with fibrosis and lobulation. The lymphoid infiltrate was arranged as lymphoid follicles and interfollicular small lymphocytes (fig 2), plasma cells, scattered lymphoplasmacytoid cells, and a few large transformed cells. Most lymphoid follicles had a well defined germinal centre and mantle zone; however, a marginal zone was not present. In five cases, plasma cells were prominent in the interfollicular region (results not shown), and four of these showed prominent fibrosis and lobulation. Histological features of low grade MALT lymphoma were not present. Specifically, effacement of thyroid acini and follicular colonisation were absent. The interfollicular area was not greatly expanded and sheets or aggregates of centrocyte-like cells, small lymphocytes, or lymphoplasmacytoid cells were not present.
Most of the lymphoid infiltrate in HT arranged as lymphoid follicles was composed of B cells (CD45+, CD20+, CD45RO−, CD3−). The interfollicular lymphoid infiltrate was composed predominantly of T cells (CD45RO+, CD3+, CD20−) admixed with a very small number of B cells and plasma cells. The B cells and plasma cells were not light chain restricted. Scattered intraepithelial B cells were present in all cases, and occasional B cell lymphoepithelial lesions were seen in five cases (fig 3). T cell non-destructive lymphoepithelial lesions were present in most (eight of 10) cases.
Molecular findings (figs 4 and 5)
Amplifiable DNA was obtained from all cases. In HT, a distinct clonal band in the appropriate region (80–160 bp) superimposed on a smear was seen in three cases, and a diffuse smear pattern (polyclonal) was seen in seven cases. Both cases of low grade MALT lymphoma had a single distinct band. In non-specific lymphocytic thyroiditis and thyrotoxicosis a diffuse smear was seen, but PCR products were not detected in DNA from unremarkable thyroid.
Reproducibility of bands
The bands were reproducible in two cases of low grade MALT lymphoma (results not shown) from deeper sections of the same paraffin wax block and from other paraffin wax blocks. The clonal bands seen in three cases of HT were not reproducible when PCR was performed on the DNA extracted from deeper sections of the same paraffin wax block or from other blocks of the same case.
In one of three cases (case 2), a clonal band was seen in at least one—either superficial or a deeper section of the same paraffin wax block. In two of three cases (cases 1 and 3), clonal bands were present in both the superficial and the deeper sections, but these were of different size. In one of these cases (case 3), not only was the size of the bands different (fig 5A), but the sequences were also different (fig 5B). In all cases with a clonal band from one paraffin wax block, the DNA from the other blocks was either polyclonal or produced a clonal band of different size. In all cases, DNA obtained from one of the three blocks was polyclonal (fig 4; case 1, lane C; case 2, lane B; and case 3, lane A). All findings (bands or smears) were confirmed by running the samples in duplicate.
Association with a background polyclonal smear
In all three cases, the clonal bands were “impure”, and were associated with a background polyclonal smear in at least one level from a paraffin wax block.
In our study, we describe the presence of clonal B cell populations in a minority (three of 10) of HT thyroid specimens that had no histological evidence of malignant lymphoma. The clonal bands were often seen against the background of a polyclonal smear and were not reproducible when deeper sections or other tissue blocks were used. None of the histopathological features correlated with B cell clonality. These clonal populations have not been associated with the subsequent development of lymphoma after a long clinical follow up (10–13 years).
A few studies (table 2) have analysed B cell clonality in HT and clonal B cell populations were not uniformly detected.7,10,12–14,23–25 These discrepancies could be the result of any of the following reasons, in addition to sampling error. The sensitivity of Southern blot analysis, usually 2–5%,17 is low compared with PCR (1/103 cells),18 and could account for negative results in the study of Ben-Ezra et al,13 although Knowles and colleagues7 were able to detect a clonal population using this technique. The immunophenotypic criteria for monoclonality20 adopted by Matsuyabashi12 (κ : λ ratio > 3 : 1 or λ : κ ratio < 2 : 1) have been revised in favour of a much greater predominance of one light chain (light chains ratio ⩾ 10 : 1),26 and the true incidence of clonality in their study was probably lower. The differences between our study and that reported by Hsi and colleagues14 could result from the selection of cases or the stage in the natural history of the disease, or might be related to the duration of the disease before thyroidectomy was performed. Hyjek and Isaacson10 used monoclonality as evidence of lymphoma; however, the five cases of HT reclassified as lymphoma had histological features of low grade MALT lymphoma. It is also possible that the high incidence of clonality reported by Tiemann et al may have included cases with lymphoma from the outset because 26 of 40 patients developed lymphoma in their series.25
In our study, B cell monoclonal populations were not found in “normal” thyroid, thyrotoxicosis, or non-specific lymphocytic thyroiditis. Two cases of low grade MALT lymphoma had pure clonal bands with no background smearing and were reproducible. The clonal populations in HT were associated with a background smear and were not “pure”. Similar findings of clonal bands against a polyclonal smear pattern have been observed in both reactive lymphoid infiltrates and some examples of malignant lymphoma,2,19,27 and reflect the background non-neoplastic B cell population. Although a pure band is considered diagnostic of lymphoma,2,28 a dominant band associated with a polyclonal smear should be interpreted cautiously in conjunction with the histopathological findings.
The clonal bands in HT were not reproducible. Of the two possible reasons for this lack of reproducibility—a low quantity of DNA19,29 or a paucity of B cell clones2,30,31—the first is unlikely because all cases of HT had florid lymphoid hyperplasia and yielded a large amount of amplifiable DNA. The second reason is more likely, and might represent selective proliferation of a small number of B cell clones as part of the autoimmune response in HT, or primer dependent preferential amplification. The observation that the CD8+ component of the T cell immune response in HT uses a restricted Vα repertoire supports the oligoclonal nature of the immune response in autoimmune diseases.32 In a manner similar to lymphoid infiltrates in the stomach,33 the lesions of HT may have a small number of scattered unique clones giving rise to bands of different sizes from different parts of the specimen. Alternatively, only a focal area may be involved, with a dominant clone producing a unique clonal band, which cannot be reproduced from other areas. The existence of a small number of clones is also supported by the demonstration of: (1) clonal populations in another autoimmune setting (salivary glands in Sjogren’s syndrome)3,4,34 and (2) non-reproducible bands in reactive and tumour follicles from B cell lymphoma.21
“In a manner similar to lymphoid infiltrates in the stomach, the lesions of Hashimoto’s thyroditis may have a small number
of scattered unique clones giving rise to bands of different sizes from different parts of the specimen”
Take home messages
B cell clonal bands in Hashimoto’s thyroiditis (HT) have different features from those in lymphoma—they are impure and not reproducible
These clonal bands do not predict the future development of lymphoma
The histological features of HT and low grade mucosa associated lymphoid tissue lymphoma often overlap, but the demonstration of B cell clonality by polymerase chain reaction is not sufficient by itself to diagnose lymphoma
HT is an established risk factor for the development of lymphoma in the thyroid.9 The presence of clonal B cells would support this link; alternatively, these clonal B cells may represent a stage in the natural history of the disease, and do not necessarily mean progression to overt lymphoma. None of the patients with HT, including three with clonal B cell populations, has developed lymphoma (follow up interval, 10–13 years). A similar scenario has been seen at other acquired MALT sites—stomach,1,2 salivary glands,3,4,7,34 skin,5,6,35 ocular adnexa,7,36 and breast7—where clonal B cells have not always progressed to frank lymphoma even after a long clinical follow up.5–7,37,38 Sometimes, histological regression and the disappearance of these clonal populations has occurred after treatment that reduces or eliminates the offending antigen.1,39,40 In addition, the monoclonal cells may not proliferate in the absence of T cell help,41 or may differentiate into terminal non-dividing cells and undergo senescence.42
Clonality is not considered synonymous with malignancy, and the concept of “multistep transformation”43 has been extended to lymphoid lesions,7,21,28 with the proposal of “monoclonal lymphoproliferative disease of undetermined significance”44 and “clonal disorder of uncertain malignant potential”28 for those lesions that are clonal but not overtly malignant. The development of lymphoma would require additional genetic events.28 In the absence of multiple lesions or masses, or characteristic histopathological features, the demonstration of clonality should not be taken as evidence of lymphoma.4,28
Because the histological features of HT and low grade MALT lymphoma often overlap, the distinction may require immunophenotyping and molecular genetic analysis. Our study has shown that the demonstration of B cell clonality by PCR is not sufficient by itself to diagnose lymphoma. This becomes even more important when interpreting fine needle aspiration cytology, which is often an initial step in evaluating thyroid lesions. In the absence of classic features of HT or lymphoma, relying on molecular evidence of clonality to diagnose lymphoma may lead to erroneous interpretation, and the pathologists should be aware of this pitfall. However, in the absence of well defined histological features of MALT lymphoma in surgical pathology specimens (lobectomy, thyroidectomy), this test should be repeated using additional blocks to confirm the reproducibility of the clonal bands. Furthermore, the clonal populations are not necessarily associated with progression to lymphoma.
We thank Mr R Cordeiro, Division of Molecular Pathology, Department of Laboratory Medicine, Saskatoon Health Region for technical assistance.